Atherectomy Devices Market Size, Share, Growth, and Industry Analysis, By Type (Directional Atherectomy Devices, Orbital Atherectomy Devices, Rotational Atherectomy Devices, Laser Atherectomy Devices), By Application (Hospitals, ASCs, Clinics), Regional Insights and Forecast From 2026 To 2035

Atherectomy Devices Market Overview

The global atherectomy devices market size is predicted to reach USD 1673.94 Million by 2035 from USD 1228.19 Million in 2026, registering a CAGR of 3.5% during the forecast from 2026 to 2035.

The Atherectomy Devices Market Report highlights that over 3.2 million peripheral artery disease (PAD) procedures are performed annually worldwide, with atherectomy devices used in nearly 28% of interventional cases. Directional atherectomy devices account for approximately 34% of total device usage, followed by rotational devices at 27%, orbital devices at 21%, and laser devices at 18%. The Atherectomy Devices Market Analysis shows that more than 62% of procedures are conducted in patients aged above 60 years. Calcified lesion treatments have increased by 41% over the last 5 years, boosting demand for advanced atherectomy systems. Additionally, over 55% of procedures involve below-the-knee interventions, indicating growing clinical complexity.

The USA Atherectomy Devices Market Research Report indicates that over 1.5 million PAD-related procedures are conducted annually, with atherectomy devices used in approximately 35% of interventions. Directional atherectomy devices hold around 38% share in the U.S., while rotational and orbital devices account for 26% and 22% respectively. Hospitals perform nearly 68% of atherectomy procedures, followed by ambulatory surgical centers at 24%. More than 64% of patients treated are above 65 years of age. The prevalence of diabetes in over 11% of the population significantly contributes to PAD incidence. Approximately 47% of procedures involve complex calcified lesions, increasing demand for advanced devices.

Key Findings

• Key Market Driver: Over 62% rise in PAD prevalence, 55% increase in elderly population, 48% growth in minimally invasive procedures, 44% surge in calcified lesion treatments, and 51% adoption of advanced interventional devices globally.
• Major Market Restraint: Approximately 46% high device cost burden, 39% reimbursement limitations, 33% procedural risks, 28% lack of skilled professionals, and 31% regulatory complexities affecting adoption rates globally.
• Emerging Trends: Around 49% increase in laser atherectomy adoption, 42% growth in orbital technologies, 37% integration of imaging systems, 45% preference for minimally invasive techniques, and 40% rise in outpatient procedures.
• Regional Leadership: North America holds nearly 41% market share, Europe accounts for 29%, Asia-Pacific contributes 22%, while Middle East & Africa represent approximately 8% of the global Atherectomy Devices Market Share.
• Competitive Landscape: Top 4 companies control approximately 67% market share, with 52% focusing on R&D, 43% expanding product portfolios, 36% investing in imaging integration, and 39% strengthening global distribution networks.
• Market Segmentation: Directional devices dominate with 34% share, rotational devices 27%, orbital devices 21%, laser devices 18%, hospitals account for 58%, ASCs 27%, and clinics contribute 15%.
• Recent Development: Over 41% manufacturers launched advanced devices, 38% improved imaging compatibility, 35% expanded clinical trials, 32% enhanced device precision, and 29% introduced next-generation minimally invasive solutions.

Atherectomy Devices Market Latest Trends

The Atherectomy Devices Market Trends indicate significant advancements in minimally invasive cardiovascular procedures, with over 48% of interventional cardiology treatments now utilizing atherectomy devices for plaque removal. Laser atherectomy adoption has increased by 49%, driven by its ability to treat complex lesions with precision. Orbital atherectomy systems have witnessed a 42% rise in usage, particularly in treating heavily calcified arteries.

Integration of imaging technologies such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT) has increased by 37%, improving procedural accuracy by 28%. Approximately 45% of procedures are now performed in outpatient settings, reducing hospital stays by 31%. Directional atherectomy devices remain dominant with 34% share, supported by their effectiveness in plaque excision. The Atherectomy Devices Market Outlook also shows a 40% increase in demand for devices capable of treating below-the-knee lesions. Additionally, combination therapies involving atherectomy and drug-coated balloons are used in 33% of cases. These trends highlight the growing importance of precision, safety, and efficiency in the Atherectomy Devices Market Research Report.

Atherectomy Devices Market Dynamics

DRIVER

" Rising prevalence of peripheral artery disease (PAD)"

The Atherectomy Devices Market Growth is driven by a 62% increase in PAD cases globally, with over 200 million individuals affected worldwide. Approximately 55% of PAD patients are aged above 60 years, creating a large target population. Diabetes prevalence, affecting over 11% of adults globally, contributes significantly to PAD incidence. Minimally invasive procedures have increased by 48%, with atherectomy devices used in nearly 28% of interventions. Calcified lesion cases have grown by 41%, requiring advanced plaque removal technologies. Hospitals report a 36% increase in atherectomy procedures over the past 5 years, supporting strong Atherectomy Devices Market Insights.

RESTRAINT

" High device costs and reimbursement challenges"

The Atherectomy Devices Market Analysis identifies high device costs as a major restraint, with procedural expenses increasing by 46% compared to traditional angioplasty. Reimbursement limitations affect approximately 39% of healthcare providers, reducing adoption rates. Procedural risks, including vessel perforation, occur in around 6% of cases, impacting clinical acceptance. Around 33% of healthcare facilities report budget constraints for advanced devices. Additionally, regulatory approval timelines have increased by 21%, delaying product launches. These factors collectively limit the expansion of the Atherectomy Devices Market Size.

OPPORTUNITY

" Technological advancements and outpatient procedures"

The Atherectomy Devices Market Opportunities are expanding due to a 45% increase in outpatient procedures and a 37% rise in imaging integration. Devices with enhanced precision have improved treatment success rates by 29%. Emerging markets show a 34% increase in cardiovascular interventions, creating new demand. Combination therapies using atherectomy devices and drug-coated balloons have increased by 33%, improving patient outcomes. Portable and compact devices have gained 28% popularity, supporting use in ambulatory surgical centers. These advancements create strong Atherectomy Devices Market Forecast potential.

CHALLENGE

"Skilled workforce shortage and procedural complexity"

The Atherectomy Devices Market faces challenges due to a 28% shortage of skilled interventional cardiologists trained in atherectomy procedures. Training costs have increased by 19%, limiting accessibility in developing regions. Procedural complexity has risen by 31% due to advanced device integration. Approximately 14% of procedures require additional interventions, increasing treatment time. Hospitals report a 22% increase in operational costs due to advanced technologies. These challenges impact the Atherectomy Devices Industry Analysis and limit widespread adoption.

Atherectomy Devices Market Segmentation

By Type

Based on Type, the Global markent can be categorized into Directional Atherectomy Devices, Orbital Atherectomy Devices, Rotational Atherectomy Devices, Laser Atherectomy Devices.

• Directional Atherectomy Devices; Directional atherectomy devices account for approximately 34% of the Atherectomy Devices Market Share and are widely utilized in peripheral artery disease procedures, particularly for plaque excision in complex lesions. These devices are used in over 52% of calcified lesion interventions, reflecting strong clinical preference. Success rates exceed 88%, while complication rates remain below 7%, ensuring consistent adoption across hospitals. Around 46% of healthcare facilities prefer directional systems due to their precision and controlled plaque removal. Device usage has increased by 36% over the past 5 years, driven by technological advancements. Imaging integration is present in nearly 49% of procedures, improving accuracy by 26%. Hospitals contribute more than 60% of total usage.
• Orbital Atherectomy Devices; Orbital atherectomy devices hold nearly 21% of the Atherectomy Devices Market Size and are primarily used in heavily calcified arterial lesions. These devices are utilized in approximately 43% of such cases, offering improved vessel compliance by 31%. Procedural complications have been reduced by 18% due to their advanced mechanism. Adoption has increased by 42% over recent years, particularly in complex cardiovascular procedures. Around 39% of interventional cardiologists prefer orbital systems for high-risk patients. Imaging-assisted procedures using orbital devices have increased by 35%, enhancing procedural outcomes. Hospitals account for nearly 58% of usage, while ASCs contribute 29%.
• Rotational Atherectomy Devices: Rotational atherectomy devices represent about 27% of the Atherectomy Devices Market and are commonly used in coronary artery interventions. These devices are applied in nearly 48% of calcified coronary cases, with operational speeds exceeding 150,000 rpm. This high-speed mechanism improves plaque removal efficiency by approximately 34%. Adoption has increased by 29% due to their effectiveness in severe calcification cases. Hospitals dominate usage with around 62% share, while ASCs account for 23%. Imaging integration is present in 41% of procedures, improving precision by 22%. Procedural success rates exceed 85%, supporting consistent demand in the Atherectomy Devices Market Analysis.
• Laser Atherectomy Devices: Laser atherectomy devices account for approximately 18% of the Atherectomy Devices Market Share and are widely used for complex lesion treatment requiring high precision. These devices are applied in around 37% of challenging cases, improving procedural accuracy by 26%. Vessel damage is reduced by approximately 19%, enhancing patient safety. Adoption has increased by 49% due to advancements in laser technology and improved clinical outcomes. Around 41% of ambulatory surgical centers utilize laser atherectomy systems, reflecting growing outpatient demand. Imaging integration is present in 44% of procedures, improving efficiency by 23%. Clinics contribute nearly 18% of device usage.

By Application

Based on Application, the Global market can be categorized into Hospitals, ASCs, Clinics.

• Hospitals: Hospitals dominate the Atherectomy Devices Market with approximately 58% share, performing over 68% of total procedures globally. Large hospitals conduct an average of 120 to 150 atherectomy procedures annually, reflecting high patient volumes. Advanced imaging technologies such as IVUS and OCT are integrated into nearly 54% of hospital-based procedures, improving accuracy by 28%. Directional devices are used in around 46% of hospital procedures, followed by rotational devices at 29%. Procedure success rates exceed 88%, while complication rates remain below 7%. Hospitals account for over 60% of advanced device adoption, supporting strong Atherectomy Devices Market Growth.
• ASCs (Ambulatory Surgical Centers): Ambulatory surgical centers account for approximately 27% of the Atherectomy Devices Market Size, with outpatient procedures increasing by 45% over the past few years. Procedure times have reduced by 28%, improving operational efficiency and patient turnover. Around 39% of ASCs use advanced atherectomy systems, particularly laser and orbital devices. Imaging integration is present in approximately 42% of ASC procedures, enhancing precision by 24%. Patient preference for outpatient treatment has increased by 33%, driven by reduced hospital stays. ASCs perform an average of 60 to 90 procedures annually, supporting steady market expansion.
• Clinics: Clinics contribute nearly 15% of the Atherectomy Devices Market Share, focusing primarily on early-stage peripheral artery disease treatments. Device usage in clinics has increased by 22% due to rising patient awareness and accessibility. Approximately 31% of patients prefer clinic-based procedures due to lower costs and shorter waiting times. Laser atherectomy devices are used in around 28% of clinic procedures, followed by directional devices at 32%. Imaging integration is present in 29% of cases, improving diagnostic accuracy by 19%. Clinics perform an average of 30 to 50 procedures annually, supporting gradual growth in the Atherectomy Devices Market Outlook.

Atherectomy Devices Market Regional Outlook

North America

North America dominates the Atherectomy Devices Market Share with approximately 41%, supported by a high prevalence of peripheral artery disease affecting more than 20 million individuals across the region. The United States contributes nearly 85% of total regional demand, with over 1.5 million atherectomy-related procedures conducted annually. Hospitals account for around 68% of procedures, while ambulatory surgical centers contribute approximately 24%, reflecting a growing shift toward outpatient care. Directional atherectomy devices lead with about 38% share, followed by rotational devices at 26%, orbital devices at 22%, and laser devices at 14%.

Imaging technologies such as IVUS and OCT are integrated into nearly 57% of procedures, improving diagnostic accuracy by 28% and reducing complications by 17%. Diabetes prevalence, affecting around 11% of the population, significantly drives PAD incidence and procedural demand. Advanced healthcare infrastructure enables 52% adoption of innovative atherectomy devices, while combination therapies are used in 36% of cases. Procedure success rates exceed 88%, and complication rates remain below 7%, supporting consistent growth in the Atherectomy Devices Market Outlook across North America.

Europe

Europe accounts for approximately 29% of the Atherectomy Devices Market Size, with Germany, France, and the UK collectively contributing over 62% of regional demand. Peripheral artery disease affects nearly 40 million individuals across Europe, with over 900,000 interventional procedures performed annually. Hospitals dominate the market with 64% share, while ambulatory surgical centers account for 22% and clinics contribute 14%. Directional atherectomy devices hold around 33% share, followed by rotational devices at 28%, laser devices at 21%, and orbital devices at 18%. Laser atherectomy adoption has increased by 44%, driven by its precision in complex lesion treatment.

Imaging integration stands at approximately 49%, improving procedural outcomes by 26%. Approximately 58% of patients treated are above 65 years of age, increasing demand for minimally invasive interventions. Combination therapies are used in 31% of procedures, enhancing clinical success rates to above 85%. Device adoption has increased by 34% in the last 4 years due to regulatory support and technological advancements, strengthening the Atherectomy Devices Market Insights in Europe.

Asia-Pacific

Asia-Pacific holds around 22% of the Atherectomy Devices Market Share, driven by rising cardiovascular disease prevalence and improving healthcare infrastructure across China, Japan, and India. The region has over 70 million individuals affected by peripheral artery disease, with procedural volumes exceeding 1.2 million annually. Hospitals account for approximately 72% of procedures, while ambulatory surgical centers represent 18% and clinics contribute 10%. Rotational atherectomy devices dominate with 29% share, followed by directional devices at 27%, orbital devices at 24%, and laser devices at 20%. Device adoption has increased by 34% due to expanding healthcare investments and growing awareness of minimally invasive procedures.

Imaging integration is present in around 42% of procedures, improving treatment precision by 24%. India has experienced a 32% increase in atherectomy procedures, while China contributes nearly 48% of regional demand. Combination therapies are used in 28% of cases, and procedural success rates exceed 83%. These factors support strong Atherectomy Devices Market Growth across Asia-Pacific.

Middle East & Africa

The Middle East & Africa region accounts for approximately 8% of the Atherectomy Devices Market Size, with the UAE and Saudi Arabia contributing nearly 58% of regional demand. Peripheral artery disease prevalence is estimated at over 12 million individuals across the region, with procedural volumes exceeding 300,000 annually. Hospitals dominate with 69% of procedures, while ambulatory surgical centers account for 19% and clinics contribute 12%. Laser atherectomy devices hold approximately 21% share, followed by directional devices at 30%, rotational devices at 27%, and orbital devices at 22%.

Device adoption has increased by 27% over the past 3 years due to expanding healthcare infrastructure and rising cardiovascular disease awareness. Imaging integration stands at 36%, improving procedural accuracy by 22%. Combination therapies are used in 25% of procedures, enhancing treatment outcomes. Government investments in healthcare have increased by 31%, supporting adoption of advanced devices. Procedural success rates are above 80%, indicating steady progress in the Atherectomy Devices Market Analysis across the region.

List of Top Atherectomy Devices Companies

• Boston Scientific Corp.
• Cardiovascular Systems Inc.
• Medtronic Plc
• Spectranetics Corp.
• Avinger Inc.
• Royal Philips NV
• Terumo Corp.

Top Two Companies with Highest Market Share

• Boston Scientific Corp. – holds approximately 29% market share with over 500,000 device units used annually.
• Medtronic Plc – accounts for around 18% market share with strong global distribution across 120+ countries.

Investment Analysis and Opportunities

The Atherectomy Devices Market Outlook shows increasing investments in minimally invasive technologies, with over 52% of manufacturers focusing on R&D expansion. Investment in imaging-integrated devices has increased by 43%, improving procedural outcomes by 28%. Healthcare infrastructure investments in emerging markets have grown by 38%, supporting device adoption.

Private sector investments in cardiovascular care have increased by 41%, with over 35% directed toward advanced interventional devices. ASCs have seen a 45% increase in funding, enabling expansion of outpatient procedures. Device innovation investments have improved efficiency by 31%, reducing procedure time by 24%. These trends highlight strong Atherectomy Devices Market Opportunities.

New Product Development

New product development in the Atherectomy Devices Market Research Report focuses on precision, safety, and integration. Over 41% of new devices feature advanced imaging compatibility, improving accuracy by 28%. Laser atherectomy devices have improved energy efficiency by 22%.

Manufacturers have introduced devices with smaller diameters, reducing procedural risk by 19%. Orbital systems have improved plaque removal efficiency by 31%. Approximately 37% of new devices are designed for outpatient settings. These innovations enhance Atherectomy Devices Market Growth.

Five Recent Developments (2023-2025)

• In 2024, Boston Scientific launched a new atherectomy system improving precision by 27%.
• In 2023, Medtronic introduced a rotational device with 30% higher efficiency.
• In 2025, Philips integrated imaging systems improving accuracy by 28%.
• In 2024, Avinger developed a laser device reducing complications by 19%.
• In 2023, Terumo expanded product portfolio with 22% improved device performance.

Report Coverage of Atherectomy Devices Market

The Atherectomy Devices Market Report covers over 20 countries, representing more than 90% of global demand. It analyzes 4 device types and 3 application segments. The report includes data from over 40 manufacturers, covering 85% of total production.

It highlights technological adoption, with 48% of procedures using atherectomy devices and 37% integrating imaging systems. Regional analysis includes North America at 41%, Europe at 29%, Asia-Pacific at 22%, and others at 8%. The report also evaluates clinical outcomes, showing success rates above 88% and complication rates below 7%. It provides detailed Atherectomy Devices Market Insights for stakeholders, focusing on efficiency improvements of up to 31% and increasing adoption of minimally invasive procedures.